First Trust Health Care AlphaDEX® ETF (FXH)

Add to Watchlists
Create an Alert
74.94 -0.34  -0.45% NYSE Arca Oct 18, 20:00 Delayed 2m USD
View Full Chart
Price Chart

Key Stats

Net Asset Value 74.93
Discount or Premium to NAV 0.01%
Turnover Ratio 123.0%
1 Year Fund Level Flows -28.74M

Performance & Returns

  Total Return (Price) Total Return (NAV) Cat. Total Return (NAV) % Rank in Cat. (NAV)
1M -0.72% -0.70% -1.42% 40
3M -3.55% -3.55% -3.14% 50
6M 5.37% 5.33% 3.58% 47
YTD 8.81% 8.77% 9.13% 46
1Y -6.48% -6.47% -4.33% 64
3Y 8.29% 8.28% 10.22% 65
5Y 6.72% 6.73% 8.28% 66
10Y 14.22% 14.22% 13.90% 45
15Y -- -- 10.80% --
20Y -- -- 10.33% --
As of Oct. 18, 2019. Returns for periods of 1 year and above are annualized.

Asset Allocation

Type % Net % Long % Short
Cash 0.17% 0.17% 0.00%
Stock 99.83% 99.83% 0.00%
Bond 0.00% 0.00% 0.00%
Convertible 0.00% 0.00% 0.00%
Preferred 0.00% 0.00% 0.00%
Other 0.00% 0.00% 0.00%
As of Oct. 17, 2019

Region Exposure

Americas 97.91%
North America 97.91%
Latin America 0.00%
Greater Europe 2.09%
United Kingdom 2.09%
Europe Developed 0.00%
Europe Emerging 0.00%
Africa/Middle East 0.00%
Greater Asia 0.00%
Japan 0.00%
Australasia 0.00%
Asia Developed 0.00%
Asia Emerging 0.00%
Market Classification
% Developed Markets 100.0%
% Emerging Markets 0.00%
As of Oct. 17, 2019. Region breakdown data is calculated by using the long position holdings of the portfolio.

Stock Sector Exposure

Basic Materials 0.00%
Communication Services 0.00%
Consumer Cyclical 0.00%
Consumer Defensive 0.00%
Energy 0.00%
Financial Services 0.00%
Healthcare 96.66%
Industrials 0.00%
Real Estate 0.00%
Technology 3.34%
Utilities 0.00%
As of Oct. 17, 2019

Stock Market Capitalization

Giant 10.67%
Large 32.12%
Medium 53.20%
Small 4.01%
Micro 0.00%
As of Oct. 17, 2019

Stock Style Exposure

Large Cap Value 15.28%
Large Cap Blend 11.83%
Large Cap Growth 15.68%
Mid Cap Value 12.00%
Mid Cap Blend 12.61%
Mid Cap Growth 28.59%
Small Cap Value 3.21%
Small Cap Blend 0.00%
Small Cap Growth 0.80%
As of Oct. 17, 2019
View More Holdings

Top 10 Holdings

Symbol Name % Weight Price % Chg
MOH Molina Healthcare Inc 2.42% 122.93 +1.18%
MD Mednax Inc 2.29% 22.95 -3.25%
HZNP Horizon Therapeutics PLC 2.29% 27.40 -3.79%
EW Edwards Lifesciences Corp 2.26% 227.46 -0.15%
BIO Bio-Rad Laboratories Inc 2.26% 343.27 -0.05%
ZTS Zoetis Inc Class A 2.25% 128.12 -0.27%
ALXN Alexion Pharmaceuticals Inc 2.23% 98.41 -1.58%
SGEN Seattle Genetics Inc 2.20% 87.40 +1.70%
CHE Chemed Corp 2.19% 417.53 -0.08%
RMD ResMed Inc 2.13% 131.21 -0.32%
As of Oct. 17, 2019
Advertisement

Basic Info

Investment Strategy
The investment seeks investment results that correspond generally to the price and yield (before the fund's fees and expenses) of an equity index called the StrataQuant® Health Care Index. The fund will normally invest at least 90% of its net assets (including investment borrowings) in common stocks that comprise the index. The index is a modified equal-dollar weighted index designed by IDI to objectively identify and select stocks from the Russell 1000® Index in the health care sector that may generate positive alpha relative to traditional passive-style indices through the use of the AlphaDEX® selection methodology.
General
Security Type Exchange-Traded Fund
Equity Style Large Cap/Growth
Fixed Income Style --
Broad Asset Class Sector Equity
Broad Category Equity
Category Name Health
Prospectus Objective Specialty - Health
Fund Owner Firm Name First Trust
Reports
One Page Report Download

Manager Info

Name Tenure
Chris Peterson 2.88 yrs
Daniel Lindquist 11.74 yrs
David McGarel 11.74 yrs
Jon Erickson 11.74 yrs
Roger Testin 11.74 yrs
Stan Ueland 11.74 yrs

Net Fund Flows

1M -26.13M
3M -86.53M
6M -1.017B
YTD -1.024B
1Y -28.74M
3Y -153.97M
5Y -1.268B
10Y 403.12M
As of Sept. 30, 2019

Risk Info

Beta (5Y) 1.031
Max Drawdown (All) 43.70%
Historical Sharpe Ratio (10Y) 1.005
Historical Sortino (All) 0.6909
30-Day Rolling Volatility 15.05%
Daily Value at Risk (VaR) 1% (All) 3.38%
Monthly Value at Risk (VaR) 1% (All) 16.40%

Fundamentals

Dividend Yield TTM (10-18-19) 0.00%
30-Day SEC Yield --
7-Day SEC Yield --
Weighted Average PE Ratio 20.57
Weighted Average Price to Sales Ratio 0.9924
Weighted Average Price to Book Ratio 3.238
Weighted Median ROE 19.12%
Weighted Median ROA 8.09%
Forecasted Dividend Yield 0.74%
Forecasted PE Ratio 15.31
Forecasted Price to Sales Ratio 0.9808
Forecasted Price to Book Ratio 2.976
Number of Holdings 80
As of Oct. 17, 2019

Growth Estimates

Forecasted 5 Yr Earnings Growth 12.47%
Forecasted Book Value Growth 8.75%
Forecasted Cash Flow Growth 1.09%
Forecasted Earnings Growth 14.74%
Forecasted Revenue Growth 8.60%
As of Oct. 17, 2019

Comparables

Edit

Attributes

Key Dates
Inception Date 5/8/2007
Termination Date
Last Annual Report Date 7/31/2019
Last Prospectus Date 11/30/2018
Attributes
Exchange Traded Share Yes
Exchange Traded Note No
Enhanced Index Fund No
Fixed Distribution Fund No
High-Net Worth Individual Fund No
Index Fund Yes
Inverse Fund No
Leveraged Fund No
Fund of Funds No
Currency Hedged Fund No
Synthetic Replication Fund No
Has Dividend Investment Plan No
Socially Responsible Fund No
General Availability
Available for Insurance Product No
Available for Retirement Plan No
Available for RRSP No
Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.